Patterns of use of antipsychotic medication in a regional community mental health service

References

• Jablensky A, McGrath J, Herrman H, et al. People living with psychotic illness: An Australian Study. National Survey of Mental Health and Wellbeing. Commonwealth of Australia. 1999, Report 4
   Google Scholar
• Kulkarni J, Power P. Initial treatment of first episode psychosis. The recognition and management of early psychosis: a preventive approach, PD McGorry, HJ Jackson. University Press, CambridgeUnited Kingdom 1999; 184–205
   Google Scholar
• Chiles JA, Miller AL, Crismon ML, Rush AJ, Krasnoff MA, Shon SS. The Texas medication algorithm project: development and implementation of the schizophrenia algorithm. Psychiatric Services 1999; 50: 69–74
   PubMed Web of Science ®Google Scholar
• Shen WW. A history of antipsychotic drug development. Comprehensive Psychiatry 1999; 40: 407–414
   PubMed Web of Science ®Google Scholar
• Tollefson GD, Beasley CM, Jr, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry 1997; 154: 457–465
   PubMed Web of Science ®Google Scholar
• Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. American Journal of Psychiatry 1994; 151: 825–835
   PubMed Web of Science ®Google Scholar
• Tollefson GD, Sanger TM. Negative symptoms: a path analytic approach to a double‐blind, placebo and haloperidol controlled clinical trial with olanzapine. American Journal of Psychiatry 1997; 154: 466–474
   PubMed Web of Science ®Google Scholar
• Ho B, Miller D, Nopoulos P, Andreasen NC. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia. Journal of Clinical Psychiatry 1999; 60: 658–663
   PubMed Web of Science ®Google Scholar
• Megna JL, Dewan M. A naturalistic study of risperidone maintenance treatment of outpatients with severe mental illness. Psychiatric Services 1999; 50: 1084–1086
   PubMed Web of Science ®Google Scholar
• Kane J, Honigfeld G, Singer J, Meltzer H. The Clozaril Collaberative Study Group. Clozapine for the treatment of the resistant schizophrenic: a double blind comparison vs. chlorpromazine/benztropine. Archives of General Psychiatry 1998; 45: 789–796
   Google Scholar
• Lee MA, Thompson PA, Meltzer HY. Effects of clozapine on cognitive function in schizophrenia. Journal of Clinical Psychiatry 1994; 55(suppl B)82–87
   PubMed Web of Science ®Google Scholar
• Meltzer HY. Suicide and Schizophrenia: Clozapine and the interSePt study. International clozaril/leponex suicide prevention trial. Journal of Clinical Psychiatry 1999; 60(suppl. 12)47–50
   Google Scholar
• Todd F, Sellman D, Robertson P. The assessment and management of people with co‐existing substance use and mental health disorders. A commissioned paper for the Alcohol Advisory Council of New Zealand. Nov., 1998. the Ministry of Health, New Zealand and the Mental Health Commission
   Google Scholar
• Keks NA, Altson K, Hope J, et al. Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service. Australian and New Zealand Journal of Psychiatry 1999; 33: 896–901
   PubMed Web of Science ®Google Scholar
• Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services 2000; 51: 216–222
   PubMed Web of Science ®Google Scholar
• Black DW, Andreasen NC. Schizophrenia, schizophreniform disorder, and delusional (paranoid) disorders. The American Psychiatric Press. Textbook of Psychiatry3rd edn., RE Hales, SC Yudofsky, JA. Talbott. American Psychiatric Press Inc., Washington 1999; 425–477
   Google Scholar
• Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatric Services 1998; 49: 196–201
   PubMed Web of Science ®Google Scholar
• Hall T. Will the new antipsychotics improve the treatment of schizophrenia?. BMJ 1993; 307: 749–750
   Web of Science ®Google Scholar
• Shen WW. Taking Issue: The need for depot atypical antipsychotics in the U.S. Psychiatric Services 1998; 49: 727
   PubMed Web of Science ®Google Scholar